Point72 (Difc) LTD Biotechnology

Point72 (Difc) LTD

$2.72 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VTYX Ventyx Biosciences, Inc.	$62.2M	$24.4 Million 0.0% of portfolio	11,157	Q4 2024 Reduced 67.74%
ADMA Adma Biologics, Inc.	$4.11B	$22.3 Million 0.0% of portfolio	1,298	Q4 2024 New
ETON Eton Pharmaceuticals, Inc.	$347M	$19.2 Million 0.0% of portfolio	1,441	Q4 2024 New
ELDN Eledon Pharmaceuticals, Inc.	$41.4M	$18.4 Million 0.0% of portfolio	4,462	Q4 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$232M	$18.1 Million 0.0% of portfolio	4,796	Q4 2024 New
QSI Quantum Si Inc	$147M	$17.8 Million 0.0% of portfolio	6,575	Q4 2024 Reduced 18.82%
PHAT Phathom Pharmaceuticals, Inc.	$181M	$15.8 Million 0.0% of portfolio	1,951	Q4 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$69.5M	$15 Million 0.0% of portfolio	4,951	Q4 2024 New
RZLT Rezolute, Inc.	$101M	$14.9 Million 0.0% of portfolio	3,035	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$12.4 Million 0.0% of portfolio	4,071	Q4 2024 Added 139.61%
INVA Innoviva, Inc.	$1.25B	$10.1 Million 0.0% of portfolio	584	Q4 2024 New
TYRA Tyra Biosciences, Inc.	$354M	$7.8 Million 0.0% of portfolio	561	Q4 2024 New
SEER Seer, Inc.	$122M	$7.24 Million 0.0% of portfolio	3,132	Q4 2024 New
RLYB Rallybio Corp	$8.68M	$5.69 Million 0.0% of portfolio	5,929	Q4 2024 Reduced 27.22%
IGMS Igm Biosciences, Inc.	$34.5M	$4.26 Million 0.0% of portfolio	697	Q4 2024 New
YMAB Y M Abs Therapeutics, Inc.	$216M	$3.82 Million 0.0% of portfolio	488	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$32.1M	$3.15 Million 0.0% of portfolio	2,203	Q4 2024 New
NAUT Nautilus Biotechnology, Inc.	$97.2M	$3.09 Million 0.0% of portfolio	1,841	Q4 2024 New
FHTX Foghorn Therapeutics Inc.	$149M	$2.4 Million 0.0% of portfolio	509	Q4 2024 New
PLX Protalix Bio Therapeutics, Inc.	$131M	$1.69 Million 0.0% of portfolio	901	Q4 2024 Reduced 92.23%
IKNA Ikena Oncology, Inc.	$42.4M	$926,000 0.0% of portfolio	564	Q4 2024 Reduced 91.6%
QURE Uni Qure N.V.	$429M	$926,000 0.0% of portfolio	52	Q4 2024 Reduced 1.89%
OMGA Omega Therapeutics, Inc.	$957K	$711,000 0.0% of portfolio	954	Q2 2024 Added 73.77%
NVCT Nuvectis Pharma, Inc.	$143M	$265,000 0.0% of portfolio	49	Q4 2024 New
AADI Aadi Bioscience, Inc.	$34.5M	$243,000 0.0% of portfolio	77	Q3 2024 Reduced 98.42%
ACET Adicet Bio, Inc.	$22.8M	$91,000 0.0% of portfolio	95	Q3 2024 Reduced 99.72%
CUE Cue Biopharma, Inc.	$28M	$72,000 0.0% of portfolio	66	Q4 2024 Added 13.79%
IMRX Immuneering Corp	$34.3M	$35,000 0.0% of portfolio	16	Q3 2024 Reduced 99.68%
VOR Vor Biopharma Inc.	$26.3M	$29,000 0.0% of portfolio	26	Q3 2024 Reduced 99.82%
BCAB Bio Atla, Inc.	$11.6M	$19,000 0.0% of portfolio	31	Q4 2024 Reduced 35.42%
BTAI Bio Xcel Therapeutics, Inc.	$53.8M	$13,000 0.0% of portfolio	35	Q4 2024 Added 12.9%
VIGL Vigil Neuroscience, Inc.	$45.5M	$12,000 0.0% of portfolio	7	Q3 2024 Reduced 99.87%
EYEN Eyenovia, Inc.	$35.2M	$11,000 0.0% of portfolio	73	Q3 2024 Reduced 99.38%
FGEN Fibrogen Inc	$28.1M	$7,000 0.0% of portfolio	13	Q4 2024 Reduced 7.14%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.